Support for funding applications
EATRIS offers a range of services to investigators preparing funding applications. The services described below can be provided for any European call involving translational research. Mainly, H2020 Societal Challenge 1 (Health, Demographic change and well-being); ERANET calls such as E-RARE, TRANSCAN, EURONANOMED, NEURONS, ERA-CVD, etc., as well as calls published by national funders and charities.
For more information, please email: Anne-Charlotte Fauvel, email@example.com
Level 1: Consortium-Building
EATRIS can help you find the right European academic partner for your consortium thanks to a comprehensive database of the high-end capabilities and expertise of 90 top tier member institutions. This service is offered free of charge to any party (EATRIS members and non-members).
If you are a member of the infrastructure, EATRIS can also support you to identify companies, charities or patient organisations for your consortium.
What are the criteria to benefit from EATRIS support for consortium building? The following basic criteria apply:
- The scope of the proposal idea must be translational;
- The PI is looking for areas of expertise and/or facilities that are crucial for project implementation.
To benefit from this service, please fill in this form and send it back to: firstname.lastname@example.org. Our team will provide you with a report listing the potential matches among EATRIS members. It is the PI’s responsibility to then liaise with the institution or organisation of interest.
Level 2: Letter of Support
EATRIS can provide coordinators with a letter of support for their proposal.
What are the criteria to obtain a letter of support?
The following criteria apply:
- The scope of the proposal must be translational and of high scientific quality;
- The proposal must be in line with EATRIS mission: “To support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes for society”;
- The consortium must be multidisciplinary with laboratory and clinical expertise represented; and when relevant, industry and/or patient organisations included as partners;
- The consortium must include institutions leading in their field and/or close collaborators of EATRIS (academic members or strategic partners);
- The proposal must explicitly commit to compliance with FAIR principles and include data management plan as a project’s deliverable.
To request a letter of support, please send the latest draft of your proposal, or at least a 3-pager including the composition of the consortium, a summary of the concept and foreseen impact, minimum four weeks before proposal submission. Please note that we are bound by confidentiality rules and will not distribute any drafts or project summaries to others without your explicit permission or request.
Level 3: Joining as partner
When relevant, EATRIS-ERIC may participate in research funding proposals as full partner providing centralised services such as Innovation Management, regulatory strategy, Health Technology Assessment or others, with member institutions involved as linked third parties if necessary.
For this level of participation, the following criteria apply:
- Proposals must meet criteria listed above for level 2;
- Feasibility of the work plan based on resources available;
- EATRIS participation would clearly add value to the consortium and the proposal is consistent with EATRIS project portfolio;
- At least one EATRIS member institution participates in the proposal as partner or could participate as linked third party of EATRIS;
- The consortium is looking for regulatory expertise, HTA support, sustainability planning, industry partnering, access to training opportunities;
EATRIS central coordination office based in Amsterdam can provide the following services:
- Innovation Management & industry partnering
Activities can include: design of the dissemination and exploitation plan of the project; definition and implementation of a monitoring plan to capture intellectual property protection needs in a timely fashion; identification of industry partnering opportunities for co-development and/or out-licensing; follow-up financing opportunities.
- Translational optimisation
Activities can include: monitoring of the project to ascertain a timely evaluation of the translational potential of the results generated during the project; full translational assessment to define follow-up validation route; early Health Technology Assessment (HTA) support.
- Regulatory support
EATRIS will leverage expertise from EATRIS affiliated institutions and perform dedicated task or work package providing regulatory support by:
- Assessing the project’s regulatory strategy and feasibility;
- Interacting with the relevant regulatory authorities;
- Answering any regulatory question arising during the project’s lifetime;
- Ensuring the project fulfils all regulatory requirements.
The services can be complemented by the scientific expertise of our institutions on preclinical and early clinical development of therapeutics , vaccines and diagnostics, with the support of enabling technologies such as biomarkers and imaging and tracing. As a research infrastructure, EATRIS can participate in funding proposals as main partner with selected affiliated parties (using Linked Third Party construct).
EATRIS Training opportunities
EATRIS can provide in-person workshops, tailor made to the needs of your project. Main topics usually include: how to assess the translational potential of your project, how to develop collaboration with industry, or an introduction to translational medicine (particularly relevant for PhD students and postdocs). For more information, we invite you to download our workshops leaflet.
These workshops can be typically offered as part of “Innovative Training Networks” proposals from the Marie Skłodowska-Curie work programme of Horizon 2020.
Level 4: EATRIS Strategic Projects
From time to time, EATRIS will take a leading role in supporting the development and management of proposals coming from EATRIS member institutes, and identified as key potential contributions to the EATRIS Strategic Research and Innovation Agenda.
The proposal must fulfil the criteria mentioned above and the following:
- The proposal idea is in line with EATRIS mission and with EATRIS Strategic Research and Innovation Agenda 2019-2022;
- The proposal is coordinated by an EATRIS institution;
- The proposal serves the research community by addressing systemic inefficiencies in medical research;
- The infrastructure can rely on strong expertise of many member institutions;
- The proposal is disruptive and will have a high impact on improving a translational pipeline, and therefore on the European Research Area.
Please contact Anne-Charlotte Fauvel for further information about EATRIS services or funding opportunities: email@example.com; +31 (0)6 50 12 98 94.